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July 2018 Volume 4, Issue 8 
 
We hope you enjoy this newsletter which is full of helpful information and 
opportunities! Also, be sure to check out our website at:  
https://umassmed.edu/ccts  
 
  
  
 
Stepped Wedge Cluster 
Randomized Designs for 
Disease Prevention 
Research 
July 11, 2018 
11:00 a.m.–12:00 noon ET 
Monica Taljaard, Ph.D.  
Senior Scientist, Clinical Epidemiology Program  
Professor, Ottawa Hospital Research Institute  
Associate Professor, School of Epidemiology and Public Health  
University of Ottawa 
 
ABOUT THIS WEBINAR 
The stepped wedge cluster randomized design has seen a rapid increase in popularity over the past 
decade. It is different than the conventional parallel arm cluster randomized design in that all clusters 
(e.g., communities, schools, or hospitals), rather than half, receive the intervention. This presentation will:  
 
• Explain the unique characteristics of the stepped wedge cluster randomized design and its 
implications for sample size calculation and analysis.  
 
• Discuss the strengths and weaknesses of stepped wedge design compared to traditional designs.  
 
ABOUT DR. TALJAARD 
 
Dr. Monica Taljaard is a Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital 
Research Institute (OHRI) and Associate Professor in the School of Epidemiology and Public Health at 
the University of Ottawa. She has a Ph.D. in Epidemiology and Biostatistics from Western University, and 
her main research interests are in the design, analysis, and ethics of cluster randomized trials. 
 
Dr. Taljaard will accept questions during the webinar via WebEx and Twitter. Use the hashtag 
#NIHMtG.  
 
Registration is Required 
Please note the registration page may not work in Firefox. 
 
Can't be there? A recording of this webinar will be available approximately one week after the session. 
You can view the full archive of previous Mind the Gap webinars on our website.  
 
This event is open to the public. Please feel free to share this information widely. 
 
For more information, please contact the Office of Disease Prevention at MindtheGap@od.nih.gov.  
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Register Now for the NCATS and FDA Gene Therapy 
Approaches to Rare Diseases Workshop 
 
Gene-based therapy is a promising and cutting-edge approach for 
the treatment of rare diseases. While these tailored therapies offer 
hope for patients, there are still many unanswered questions.  
 
To help facilitate discussion among academic, government and 
industry researchers, NCATS and the Food and Drug 
Administration’s Center for Biologics Evaluation and Research will 
co-host “The Growing Promise of Gene Therapy Approaches to Rare Diseases” workshop on Aug. 20-21, 
2018. The event will take place at the National Institutes of Health main campus in Bethesda, Maryland. 
The goals of this two-day workshop include:  
 
1. Reviewing the state of current gene therapy approaches;  
2. Identifying challenges to and strategies for advancing gene therapy research; and  
3. Discussing how to collaboratively scale and accelerate gene therapy development to benefit 
patients with rare diseases that currently lack effective treatments.  
 
Register now.  
View the agenda.  
Learn more about the event 
 
 
 
 
 
  
  
***FUNDING OPPORTUNITIES*** 
CCTS SPARK Program 
Application Deadline: Rolling Basis 
THE UMCCTS SPARK (Small Pilot and Research Knowledge) Program’s priorities are to support studies 
that impact clinical care and research methodologies, support students and trainees, and provide access 
to funds to generate pilot and preliminary data for external grant submissions. 
For more information please see https://umassmed.edu/ccts/funding/spark-program/  
CCTS Small Conference Grants 
Application Deadline: Rolling Basis 
THE UMCCTS is pleased to offer Small Conference Grants (SCG). This funding facilitates the 
development of faculty-to-faculty networks within the University system. 
For more information please see https://umassmed.edu/ccts/funding/small-conference-grants/  
 
Funding Opportunities for the Rare Diseases Clinical Research Network (RDCRN) 
 
The National Center for Advancing Translational Sciences (NCATS) Office of Rare Diseases Research 
(ORDR) is pleased to announce that two Funding Opportunity Announcements (FOAs) have published 
for the Rare Diseases Clinical Research Network (RDCRN). 
Rare Diseases Clinical Research Consortia (RDCRC) 
We are inviting applications for new and renewal applications of the Rare Diseases Clinical Research 
Consortia that comprise the RDCRN. The RDCRCs are intended to advance the diagnosis, management, 
and treatment of rare diseases with a focus on clinical trial readiness. Each RDCRN will promote highly 
collaborative, multi-site, patient-centric, translation and clinical research with the intent of addressing 
unmet clinical trial readiness needs. 
Data Management and Coordinating Center (DMCC) 
We are inviting applications for the Data Management and Coordinating Center (DMCC) for the RDCRN. 
The DMCC will facilitate and support the activities of each RDCRC along with trans-network activities that 
broadly facilitate the advancement of rare diseases research via four Cores: 1) Administrative; 2) Data 
Management; 3) Clinical Research; and 4) Engagement and Dissemination. 
The full criteria and description for both new FOAs are published here:  
1. RDCRC: https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-18-020.html  
2. DMCC: https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-18-021.html  
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Please contact Nate Hafer (Nathaniel.hafer@umassmed.edu) for more information or if you are 
interested in applying.  
 
  
  
***Save The Date*** 
UMMS-Baystate Celebration of Research and Academic Innovation 
 
Please join us for our annual daylong Celebration of Research and Academic Innovation on September 
12th, 2018. This year our Keynote Speaker will be Dr. David Asch, MD, MBA, Executive Director of the 
Penn Medicine Center for Health Care Innovation & Professor of Health Care Management, the Wharton 
School. He will present Behavioral Economics: Understanding how patients & physicians make medical 
choices in clinical, financial, and ethically charged settings” at Grand Rounds (8:00 am in Chestnut 1A/B) 
and also give a noon-time lecture (Chestnut 5).  
 
In addition for an opportunity to “Meet the Professor” (Dr. Asch), there will be symposia and workshops 
on a variety of topics throughout the day with the goal of promoting research among Baystate faculty and 
staff. From 9:00am to 6:00 pm posters will be available for viewing in the Health Sciences Library, 
Chestnut Conference Center.  
 
To submit a poster, please email it to: AcademicWeek@BaystateHealth.org by 5PM on Wed., August 1
st
.  
Questions? Contact Susan Decelle, Susan.Decelle@baystatehealth.org  
 
  
  
***Learning Opportunities*** 
K Club 2.0 
The UCCTS Research Career & Writing Group (K-Club 2.0) was established in 2007. The group meets 
every first and third Wednesday to provide information and feedback on academic career development 
and on preparing a Research Career Award application (NIH K Awards, VA Research Career Awards, 
CTSA K12 grants, etc.). Faculty receive feedback on CV developments, help on preparing NIH 
biosketches as well as a wealth of other information.  
Where: 1st and 3rd Wednesday of the month from 4:00pm - 5:00pm in AS6-2072 
More information: www.umassmed.edu/ccts/education/k-club  
 
 
I Corps Program  
 
APPLY NOW! 
Application Deadline September 17, 2018. 
Does your latest discovery have commercial value? Would a potential "customer" of your research welcome 
your technology, protocol, or intervention? 
The I-Corps Program at the UMCCTS, a joint MassTERi/UMass Center for Clinical and Translational 
Science (UMCCTS) initiative, is designed to support the translation of biomedical research by providing 
early-stage education and strategic guidance to faculty, staff and students during the ideation phase of 
technology development. 
Course starts on October 23, 2018. Please go to: 
https://umassmed.edu/ccts/education/i-corps-program-at-the-umccts/ 
Questions? Contact Nate Hafer at 508-856-2511 
 
University of Massachusetts Medical School  
Transdisciplinary Training in Cardiovascular Research (T32) 
 
Request for Trainee Applications 
 
UMass has a cardiovascular T32 training grant entitled "Transdisciplinary Training in Cardiovascular 
Research" under the direction and senior leadership of Drs. Catarina Kiefe and John Keaney. The 
program represents a unique opportunity for the institution to promote the entire spectrum (T0 – T5) of 
cardiovascular research on our campus. We are writing to request applications from trainees who wish to 
become part of this exciting program at the postdoctoral level. New trainees will join 4 other current 
trainees in the program. 
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For more information, including how to apply, contact Rebecca Gigliello at 
Rebecca.Gigliello@umassmed.edu  
 
  
  
CTSA Program hubs collaborate to help researchers navigate regulatory environment 
 
Three North Carolina Clinical and Translational Science Awards (CTSA) Program hubs have collaborated 
to create a platform for sharing regulatory expertise and best practices. The Regulatory Guidance for 
Academic Research of Drugs and Devices (ReGARDD) Program provides researchers with regulatory 
guidance, education, and consultative support, to ultimately help them move promising products and 
novel discoveries to clinical trials. 
ReGARDD, which is coordinated by the hubs at Duke University, the Wake Forest School of Medicine, 
and the University of North Carolina at Chapel Hill (UNC-Chapel Hill) with partner RTI International, 
officially launched in 2015 and has been developing since. The program builds upon the existing services 
and knowledge of the North Carolina CTSA Program Regulatory Groups and the Research Triangle Park 
(RTP). 
>> READ THE FULL STORY.  
Visit the ReGARDD Program website.  
 
  
  
***Share Your Success!!*** 
Have you had research published that cites the UMass Center for Clinical and Translational Science? 
Has a patent been filed on technology developed using Center funding or resources? Did your pilot 
project receive external grant funding? Share it with us at ccts@umassmed.edu . Sharing your successes 
helps show the importance and the effect of the Center for Clinical and Translational Science at UMass.  
 
  
  
STAY CONNECTED 
    
  
 
 
University of Massachusetts Center for Clinical and Translational Science | Ambulatory Care Center, 362 
Plantation Street, Worcester, MA 01605  
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